IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 207 filers reported holding IMMUNOGEN INC in Q1 2018. The put-call ratio across all filers is 3.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $576,000 | +85.8% | 112,765 | -11.9% | 0.03% | +75.0% |
Q3 2019 | $310,000 | -7.7% | 127,945 | -17.4% | 0.02% | -15.8% |
Q2 2019 | $336,000 | -72.1% | 154,902 | -65.2% | 0.02% | -73.6% |
Q1 2019 | $1,206,000 | +161.6% | 445,118 | +813.2% | 0.07% | +242.9% |
Q3 2018 | $461,000 | -52.6% | 48,745 | -47.3% | 0.02% | -46.2% |
Q1 2018 | $972,000 | -23.5% | 92,456 | -44.3% | 0.04% | -40.0% |
Q3 2017 | $1,270,000 | +392.2% | 166,036 | +97.5% | 0.06% | +400.0% |
Q2 2016 | $258,000 | -91.8% | 84,049 | -76.2% | 0.01% | -88.1% |
Q1 2015 | $3,157,000 | +113.6% | 352,751 | +45.5% | 0.11% | +98.2% |
Q4 2014 | $1,478,000 | +189.2% | 242,432 | +607.5% | 0.06% | +103.7% |
Q1 2014 | $511,000 | -67.8% | 34,268 | -63.2% | 0.03% | -68.6% |
Q3 2013 | $1,585,000 | -42.7% | 93,173 | -44.1% | 0.09% | -5.5% |
Q2 2013 | $2,766,000 | – | 166,744 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 3,984,734 | $15,421,000 | 1.00% |
Moloney Securities Asset Management, LLC | 274,450 | $1,062,000 | 0.55% |
Schonfeld Strategic Advisors LLC | 1,025,176 | $3,968,000 | 0.40% |
Orbimed Advisors | 6,095,647 | $23,590,000 | 0.27% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $438,000 | 0.26% |
PINNACLE ASSOCIATES LTD | 1,589,959 | $6,153,000 | 0.12% |
Baker Brothers Advisors | 3,015,353 | $11,669,000 | 0.10% |
BAXTER BROS INC | 58,000 | $224,000 | 0.07% |
SIMON QUICK ADVISORS, LLC | 25,000 | $97,000 | 0.06% |
ClearBridge Investments | 14,428,856 | $55,840,000 | 0.06% |